2018-2019 Research Grant Fellow Recipients Announced

Press ReleaseLung Cancer Initiative of North Carolina

FOR IMMEDIATE RELEASE ON AUGUST 9, 2018

Contact: Megan Snowdowne

Marketing & Communications Manager

Lung Cancer Initiative of North Carolina

(919) 784-0410 ext. 102

msnowdowne@lungcancerinitiativenc.org

 

 

$125,000 in Grants Awarded for Lung Cancer Research in North Carolina

 

August 9, 2018 (NORTH CAROLINA) - The Lung Cancer Initiative of North Carolina (LCI) is pleased to announce the recipients of the 2018-2019 Lung Cancer Research Fellowship Grant.  Each grantee will receive $25,000 and is selected based on the measurable impact of their proposal and commitment to the lung cancer field.    

 

“We are incredibly pleased to introduce this year’s recipients from across the state and to learn more about each of their areas of focus,” said Amy Cipau, President of Lung Cancer Initiative.  “While the goal of the LCI research program is to encourage researchers to enter the field, we’ve also had several fellows who have gone on to receive continued funding for their work from other groups like the National Institutes of Health and others.”

 

2018-2019 Lung Cancer Initiative Fellowship Grant Recipients

 

 

Michael H. Soike, MD (Wake Forest Baptist Medical Center)

Project Title: Single Cell RNA Sequencing of Lung Cancer Brain Metastases

 

Emily Ray, MD, MPH (University of North Carolina at Chapel Hill)

Project Title: Patterns and predictors of unplanned emergency department visits and readmissions in patients with newly diagnosed lung cancer

 

Zachary L. Farmer, MD (Levine Cancer Institute)

Project Title: A randomized trial of a mobile application to track symptoms reported by patients with lung cancer

 

Jacob M. Kaufman, MD, PhD (Duke University Medical Center)

Project Title: Systematic characterization of pathway dependencies in LKB1 deficient lung cancer

 

Abdul Rafeh Naqash, MD (Brody School of Medicine at East Carolina University)

Project Title: A pilot study aimed at assessing the role of adenosine A2A receptor in modulating the immune response in non-small cell lung cancer patients treated with immune checkpoint blockade

 

Each fellow will present his or her work at the LCI Annual Meeting on February 24, 2019.

Annually, lung cancer claims more lives in the US than any other cancer and more than breast, colon and prostate cancers combined, and yet it also remains greatly underfunded.  Since 2008, LCI has funded more than $1.6 million in lung cancer research.

 

About Lung Cancer Initiative of North Carolina

As the state’s leading non-profit organization supporting lung cancer research and education, the Lung Cancer Initiative of North Carolina specializes in connecting patients, survivors and loved ones with the medical and research community. The organization’s mission is to save lives and provide support to those affected by lung cancer through research, awareness, education and access programs across North Carolina.  For more information, please visit www.LungCancerInitiativeNC.org.

###



Comments

Leave a Reply

(0 / 500)

GuideStar Gold Participant